AVGO's third-quarter fiscal 2024 results benefit from strong demand for AI networking and VMware solutions. However, shares fall on weak Q4 guidance.
Vous n'êtes pas connecté
Cardinal Health's (CAH) fourth-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
AVGO's third-quarter fiscal 2024 results benefit from strong demand for AI networking and VMware solutions. However, shares fall on weak Q4 guidance.
PD's second-quarter fiscal 2025 results benefit from an expanding customer base. However, weak top-line guidance negatively impacts share price.
ALK raises its third-quarter 2024 adjusted earnings per share guidance to the range of $2.15-$2.25 from the previously guided range of $1.40 to $1.60.
ALK raises its third-quarter 2024 adjusted earnings per share guidance to the range of $2.15-$2.25 from the previously guided range of $1.40 to $1.60.
DKS posts robust second-quarter fiscal 2024 results, thanks to the solid execution of its strategic efforts.
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Zscaler's fiscal fourth-quarter performance reflects increased success in selling bigger bundles and strong customer traction for the Zero Trust...
Zscaler's fiscal fourth-quarter performance reflects increased success in selling bigger bundles and strong customer traction for the Zero Trust...
Academy Sports' second-quarter fiscal 2024 results reflect soft demand trends due to macroeconomic uncertainties.
Hormel Foods' third-quarter fiscal 2024 results reflect lower sales and earnings amid weaker-than-expected commodity markets. Management cuts fiscal...